BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2020 10:54:23 AM | Browse: 706 | Download: 913
 |
Received |
|
2019-11-25 16:20 |
|
Peer-Review Started |
|
2019-11-25 16:20 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-12-23 13:38 |
|
Revised |
|
2020-01-14 15:30 |
|
Second Decision |
|
2020-01-18 10:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-01-18 18:43 |
|
Articles in Press |
|
2020-01-18 18:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-02-19 23:09 |
|
Typeset the Manuscript |
|
2020-03-04 12:06 |
|
Publish the Manuscript Online |
|
2020-03-06 10:54 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Results of meta-analysis should be treated critically
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rong-Qiang Liu and Yi Shao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81400372 |
| Youth Science Foundation of Jiangxi Province |
20151BAB21516 |
| Science and Technology Plan Project of Jiangxi Province |
20151BBG70223 |
| Association for Science and Technology of Jiangxi Province |
20111BBG70026-2 |
| Science and Technology Plan of Jiangxi Provincial Health and Family Planning Commission |
20164017 |
| Science and Technology Plan of Jiangxi Provincial Health and Family Planning Commission |
20155154 |
|
| Corresponding Author |
Yi Shao, MD, PhD, Director, Doctor, N/A, Department of Ophthalmology, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China Freebee99@163.com., Nanchang 330006, China. freebee99@163.com |
| Key Words |
Proton pump inhibitor; Hepatic encephalopathy; Liver disease; ; ; |
| Core Tip |
Proton pump inhibitors (PPIs) have been widely used in patients with liver disease. In general, PPIs are considered safe. However, accumulating evidence indicates that long-term and excessive use of PPIs without clear indication can lead to serious adverse reactions. Some epidemiological studies have investigated the association of PPI use with the risk of hepatic encephalopathy. However, the results are controversial. The study reveals that PPI use increases hepatic encephalopathy risk in patients with liver disease. This reminds clinicians should be more cautious to use PPIs in patients with liver disease. |
| Publish Date |
2020-03-06 10:54 |
| Citation |
Liu RQ, Shao Y. Results of meta-analysis should be treated critically. World J Gastroenterol 2020; 26(9): 992-994 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i9/992.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i9.992 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
